Abstract
Cancer induction by the non-genotoxic mycotoxin, fumonisin B1, has been investigated by studying the mechanisms involved during cancer initiation and promotion in rat liver. Cancer initiation is effected through a toxic-proliferative response while the inhibitory effect on hepatocyte cell proliferation appears to be a key aspect determining cancer promotion. Dose-response effects of the fumonisins on the induction of early neoplastic lesions in both long- and short-term animal experiments have been established. The biphasic response of FB1 on hepatocyte proliferation will be discussed in relation to the known mechanisms of cancer induction by the genotoxic hepatocarcinogens. Recent investigations regarding the effect of the fumonisins on lipid biosynthesis and its inhibitory effect on hepatocyte growth stimulatory responses in vitro will be highlighted. Integration of our current knowledge regarding the carcinogenic potential of the fumonisins in setting a realistic and applicable risk assessment model for this non-genotoxic carcinogen will finally be addressed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ames, B.N.; Gold, L.S. Dietary carcinogens, environmental pollution, and cancer: some misconceptions. Med. Oncol. & Tumor Pharmacother. 1990, 7, 69–85.
Barstch, H.; Ohshima, H.; Pignatelli, B.; Calmeis, S. Endogenously formed N-nitroso compounds and nitrosating agents in human etiology. Pharmacogenetics 1992, 2, 272–277.
Begin, M.E.; Ells, G.; Horribin, D.F. Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J. Natl. Cancer Inst. 1992, 80, 188–194.
Bishop, J.M. The molecular genetics of cancer. Science 1987, 235, 305–311.
Bressac, B.; Kew, M.; Wands, J.; Ozturk, M. Selective G to T mutations of the p53 gene in hepatocellular carcinoma from South Africa. Nature 1991, 350, 429–432.
Butterworth, B.E.; Goldsworthy, T.L. The role of cell proliferation in multistage carcinogenesis. Proc. Soc. Exp. Biol. Med. 1991, 683-687.
Chamberlain, W.J.; Bacon, C.W.; Norred, W.P.; Voss, K.A. Levels of fumonisin B1 in maize naturally contaminated with aflatoxins. Fd. Chem. Toxic. 1993, 31, 995–998.
Cawood, M.E.; Gelderblom, W.C.A.; Alberts, J.F.; Snyman, S.D. Interaction of 14C-labelled fumonisin B mycotoxins with primary hepatocytes cultures. Fd Chem. Toxicol. 1994, 32, 627–632.
Cohen, S.M.; Ellwein, L.B. Cell proliferation in carcinogenesis. Science 1990, 249, 1007–1011.
Cohen, S.M.; Ellwein, L.B. Carcinogenesis mechanisms: The debate continues. Science 1991, 252, 902–904.
Columbano, A.; Ledda-Columbano, G.M.; Coni, P.; Pichiriconi, G.; Curto, M.; Pani, P. Chemically induced cell proliferation and carcinogenesis: differential effect of compensatory cell proliferation and mitogen-induced direct hyperplasia on hepatocarcinogenesis in the rat. Progress. Clin. Biol. Res. 1991, 369, 211–225.
Chu, F.S.; Li, G.Y. Simultaneous occurence of fumonisin B1 and other mycotoxins in moldy maize collected from People’s Republic of China in regions with high incidences of esophageal cancer. Appl. Environ. Microbiol. 1994, 60, 847–852.
Farber, E. Clonal adaptation during carcinogenesis. Biochem. Pharmacol. 1983, 39, 1837–1846.
Farber, E.; Chen, Z-Y.; Harris, L.; Lee, G.; Rinaudo, J.S.; Perera, F.P. Molecular cancer epidemiology: A new tool on cancer prevention. J. Natl. Cancer Inst. 1987, 78, 887–897.
Farber, E.; Chen, Z-Y.; Harris, L.; Lee, G.; Rinaudo, J.S.; Roomi, W.M.; Rotstein, J.; Semple, E. The biochemical-molecular pathology of the stepwise development of liver cancer: new insights and problems. In Liver Cell Carcinoma; Bannasch, P., Keppler, D., Weber, G., Eds.; Kluwer Academic Publishers: Dordreccht, Boston, London, 1989; pp 273–291.
Farber, E. Hepatocyte proliferation in stepwise development of experimental liver cell cancer. Digest. Disease and Science 1991, 36, 973–978.
Farber, E.; Rubin H. Cellular adaptation in the origin and development of cancer. Cancer Res. 1991, 51, 2751–2761.
Farber, E. Is carcinogenesis fundamentally adversarial confrontational or physiologic-adaptive? J. Invest.Dermatol. 1993, 100, 251s–253s.
Gavino, V.C.; Miller, J.S.; Ikharebha, S.O.; Milo, G.E.; Maizewell, D.G. Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures. J. Lipid Res. 1981, 22, 763–769.
Gelderblom, W.C.A.; Jaskiewics, K.; Marasas, W.F.O.; Thiel, P.G.; Horak, R.M.; Vleggaar, R.; Kriek, N.P.J. Fumonisins-novel cancer promoting activity produced by Fusarium moniliforme. Appl. Environ. Microbiol. 1988, 54, 1806–1811.
Gelderblom, W.C.A.; Snyman, S.D. Mutagenicity of potentially carcinogenic mycotoxins produced by Fusarium moniliforme. Mycotoxin Res. 1991, 7, 46–52.
Gelderblom, W.C.A.; Kriek, N.P.J.; Marasas, W.F.O.; Thiel, P.G. Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis 1991, 12, 1247–1251.
Gelderblom, W.C.A.; Semple, E.; Farber, E. The cancer initiating potential of the fumonisin mycotoxins produced by Fusarium moniliforme. Carcinogenesis 1992, 13, 433–437.
Gelderblom, W.C.A.; Cawood, M.E.; Snyman, S.D.; Vleggaar, R.; Marasas, W.F.O. Structure-activity relationships of fumonisins in short-term carcinogenesis and cytotoxicity assays. Fd. Chem. Toxicol. 1993, 31, 407–414.
Gelderblom, W.C.A.; Cawood, M.E.; Snyman, S.D.; Marasas, W.F.O. Fumonisin B1 dosimetry in relation to cancer initiation in rat liver. Carcinogenesis 1994, 15, 209–214.
Gelderblom, W.C.A.; Snyman, S.D.; Van der Westhuizen, L.; Marasas, W.F.O. Mitoinhibitory effect of fumonisin B1 on rat hepatocytes in primary culture. Carcinogenesis 1995, 16, 625–631.
Gelderblom, W.C.A.; Snyman, S.D.; Cawood, M.E.; Smuts C.M.,; Abel, S. and Van der Westhuizen, L. Effect of fumonisin B1 on protein and lipid synthesis in primary hepatocytes. Food Chem Toxicol. 1996, In press.
Ghoshal, A.K.; Rushmore, T.H.; Farber, E. Initiation of carcinogenesis by a dietary deficiency of choline in the absence of added carcinogens. Cancer Lett. 1987, 36, 289–296.
Grasl-Kraupp, B.; Waldhor, T.; Huber, W.; Schulte-Herman, R. Glutathione S-transferase isoenzymes patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital. Carcinogenesis 1993, 14, 2407–2412.
Halliwell, B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence. The Lancet 1994, 344, 721–724.
Handler, J.A.; Danilowics, M.; Eling, T.E. Mitogenic signalling by epidermal growth factor requires arachidonic acid metabolism in BALB/c 3T3 cells. J. Biol Chem. 1990, 265, 3669–3673.
Hoel, D.G.; Haseman, J.K.; Hogan, M.D.; Huff, J.; McConnell, E. The impact of toxicity on carcinogenicity studies: implications for risk assessment. Carcinogenesis 1988, 9, 2045–2052.
Huber, W.W.; Kraupp-Grasl, B.; Gschwentner, C. Influence of cicadian rhythm, feeding rhythm and fat charge on lipid peroxidation under peroxisome proliferation by nafenopin. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1992, 345 Suppl. 153.
Kato, T.; Imaida, K.; Ogawa, K.; Hesegawa, R.; Shirai, T.; Tatematsu, M. Three-dimensional analysis of glutathione S-transferase placental form-positive lesion development in early stages of rat hepatocarcinogenesis. Jpn. J. Cancer Res. 1993, 84, 1252–1257.
Kraupp-Grasl, B.; Huber, W.; Taper, H.; Schulte-Hermann, R. Increased susceptibility of aged rats to hepato-carcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res. 1991, 51, 666–671.
Kuiper-Goodman, T. Uncertainties in the risk assessment of three mycotoxins: aflatoxin, ochratoxin, and zearalenone. Can.J. Physiol. Pharmacol. 1990, 68, 1017–1024.
Manjeshwar, S.; Rao, P.M.; Rajalakshmi, S.; Sarma, D.S.R. Inhibition of DNA synthesis by phenobarbital in primary cultures of hepatocytes from normal liver and from hepatic nodules. Carcinogenesis 1992, 13, 2287–2291.
Maizewell, D.G.; Morisaki, N. Fatty acid paradoxes in the control of cell proliferation: prostaglandins, lipid peroxides, and co-oxidation reactions. In Free Radicals in Biology VI; Pryor, W.A., Ed.; Academic Press INC: Orlando, Florida, USA, London, 1984; pp 95–148.
Melnick, R.L.; Huff, J. Liver carcinogenesis is not a predictive outcome of chemically induced hepatocyte proliferation. Toxicol. Indust. Health 1993, 9, 415–438.
Morisaki, N.; Lindsey, J.A.; Milo, G.E.; Maizewell, D.G. Fatty acid metabolism and cell proliferation. Effect of prostaglandin biosynthesis either from exogenous fatty acid metabolism or endogenous fatty acid release with hydralazine. Lipids 1983, 18, 349–352.
Nagai, M.K.; Armstrong, D.; Farber, E. Induction of resistant hepatocytes by clofibrate, a non-genotoxic carcinogen. Proc. Am. Ass. Cancer Res. 1993, 34, 164.
Nolan, R.D.; Danliowicz, R.M.; Eling, T.E. Role of arachidonic acid metabolism in the mitogenic response of Balb/c 3T3 fibroblasts to epidermal growth factor. Molecular Pharmacol. 1988, 33, 650–656.
Norred W.P; Plattner, R.D.; Vesonder, R.F.; Bacon, C.W.; Voss, K.A. Effects of selected secondary metabolites of Fusarium moniliforme on unscheduled synthesis of DNA by primary rat hepatocytes. Fd. Chem. Toxicol. 1992, 30, 233–237.
Pichiriconi, G.; Coni, P.; Laconi, E.; Schwarze, P.E.; Seglen, P.O.; Rao, P.M.; Rajalakshimi, S.; Sarma, D.S.R. Studies on the mitoinhibitory effect of orotic acid on hepatocytes in primary culture. Carcinogenesis 1990, 77, 981–984.
Rao, M.S.; Reddy, J.K. An overview of peroxisome proliferator-induced hepatocarcinogenesis. Environ. Health Perspect. 1991, 93, 205–209.
Reifferscheid, G.; Heil, J.; Oda, Y.; Zahn, R.K. A microplate version of SOS/umu-test for rapid detection of genotoxins and genotoxic potential of environmental samples. Mutat Res. 1991, 253, 215–222.
Rheeder, J.P.; Marasas, W.F.O.; Thiel, P.G.; Sydenham, E.W.; Shephard, G.S.; Van Schalkwyk, D.J. Fusarium moniliforme and fumonisins in maize in relation to human esophageal cancer in Transkei. Phytopathology 1992, 82, 353–357.
Rheeder, J.P.; Sydenham, E.W.; Marasas, W.F.O.; Thiel, P.G.; Shephard, G.S.; Schlecther, M.; Stockenström, S.; Cronje, D.E.; Viljoen, T.H. Ear-rot fungi and mycotoxins in South Africa maize of the 1989 crop exported to Taiwan. Mycopathologia 1994, 727, 35–41.
Roomi, W.M.; Rotstein, J.; Semple, E. The biochemical-molecular pathology of the stepwise development of liver cancer: new insights and problems. In The molecular biology of carcinogenesis; Bannasch, P., Keppler, D., Pitot, H.C. Cancer 1993, Suppl. 72, 962–970.
Ross, R.K.; Yaun, J.M.; Yu, M.C.; Wogan, G.N., Qian, G.S. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992, 339, 9343–9346.
Satoh, K.; Hatayama, I.; Tateoka, N.; Tamai, K.; Shimizu, T.; Tatematsu, M.; Ito, N.; Sato, K. Transient induction of single GST-P positive hepatocytes by DEN. Carcinogenesis 1989, 10, 2107–2111.
Sheffield, V.C.; Beck, J.S.; Kwitek, A.E.; Sandstrom, D.W.; Stone, E.M. The sensitivity of single-strand conformation polymorphism analyses for the detection of single base substitutions. Genomics 1993, 16, 325–332.
Shephard, G.S.; Thiel, P.G.; Sydenham, E.W.; Alberts, J.F.; Gelderblom, W.C.A. Fate of single dose of the 14C-labelled mycotoxin, fumonisin B1 in rats. Toxicon 1992, 30, 768–770.
Smith, J.E.; Lewis, C.W.; Anderson, J.G.; Solomons, G.L. Eds.; Mycotoxins in human nutrition and health. Directorate-General X11, Science, Research and Development, EUR 16048 EN, 1994, pp 43-48.
Sydenham, E.W.; Shephard, G.S.; Thiel, P.G.; Marasas, W.F.O.; Stokenström, S. Fumonisin contamination of commercial maize-based human foodstuffs. J. Agric. Food Chem. 1991, 39, 2014–2018.
Thiel, P.G.; Marasas, W.F.O.; Sydenham, E.W.; Shephard, G.S.; Gelderblom, W.C.A. The implications of naturally occurring levels of fumonisins in maize for human and animal health. Mycopathologia 1992, 777, 3–9.
Viljoen, J.H.; Marasas, W.F.O.; Thiel P.G. Fungal infection and mycotoxin contamination of commercial maize. In Cereal Science and Technology: Impact on a Changing South Africa; Taylor, J.R.N., Randall, P.G., Viljoen, J.H., Eds.; CSIR, Pretoria, 1993.
Voss, K.A.; Chamberlain, W.J.; Bacon, C.W.; Norred, W.P. A preliminary investigation on renal and hepatic toxicity in rats fed purified fumonisin B1. Natural Toxins 1993, 1, 222–228.
Ward, J.M.; Henneman, J.R. Naturally-occurring age-dependent glutathione S-transferase P immunoreactive hepatocytes in aging female F344 rat liver as potential promotable targets for non-genotoxic carcinogens. Cancer Lett. 1990, 52, 187–195.
Ward, J.F.; Limoli, C.L.; Calabro-Jones, P.; Evans, J.W. Radiation vs. chemical damage to DNA. In Anticarcinogenesis and Radiation Protection; Cerutti P.A., Nygaard, O.F., Simic, M.G., Eds.; Plenum Press: New York, 1987.
Weinstein, I.B. Nonmutagenic mechanism in carcinogenesis: role of protein kinase C in signal transduction and growth control. Environ. Health Perspec. 1991, 93, 175–179.
Yoo, H.; Norred, W.P.; Wang, E.; Merrill A.H.(Jr); Riley, R.T. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells. Toxicol Appl. Pharmacol. 1992, 114, 9–15.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gelderblom, W.C.A. et al. (1996). Hepatotoxicity and -Carcinogenicity of the Fumonisins in Rats. In: Jackson, L.S., DeVries, J.W., Bullerman, L.B. (eds) Fumonisins in Food. Advances in Experimental medicine and Biology, vol 392. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1379-1_24
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1379-1_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1381-4
Online ISBN: 978-1-4899-1379-1
eBook Packages: Springer Book Archive